Dinesh Talwar

Dr. Dinesh Talwar


Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 December 2016 in JCI Insight
Verified
Journal Article
Open access
PDF file
CBCraig Balmforth
Craig Balmforth
JBJob van Bragt
Job van Bragt
TRTitia Ruijs
Titia Ruijs
JCJames R. Cameron
James R. Cameron
RKRobert Kimmitt
Robert Kimmitt
NDNeeraj Dhaun
Neeraj Dhaun
BACKGROUND. Chronic kidney disease (CKD) is strongly associated with cardiovascular disease and there is an established association between vasculopathy affecting the kidney and eye. Optical coherence tomography (OCT) is a novel, rapid method for high-definition imaging of the retina and choroid. Its use in patients at high cardiovascular disease risk remains unexplored. METHODS. We used the new SPECTRALIS OCT machine to examine retinal and retinal nerve fiber layer (RNFL) thickness, macular volume, and choroidal thickness in a prospective cross-sectional study in 150 subjects: 50 patients with hypertension (defined as a documented clinic BP greater than or equal to 140/90 mmHg (prior to starting any treatment) with no underlying cause identified); 50 with CKD (estimated glomerular filtration rate (eGFR) 8–125 ml/min/1.73 m 2 ); and 50 matched healthy controls. We excluded those with diabetes. The same, masked ophthalmologist carried out each study. Plasma IL-6, TNF-α , asymmetric dimethylarginine (ADMA), and endothelin-1 (ET-1), as measures of inflammation and endothelial function, were also assessed. RESULTS. Retinal thickness, macular volume, and choroidal thickness were all reduced in CKD compared with hypertensive and healthy subjects (for retinal thickness and macular volume P < 0.0001 for CKD vs. healthy and for CKD vs. hypertensive subjects; for choroidal thickness P < 0.001 for CKD vs. healthy and for CKD vs. hypertensive subjects). RNFL thickness did not differ between groups. Interestingly, a thinner choroid was associated with a lower eGFR ( r = 0.35, P <0.0001) and, in CKD, with proteinuria ( r = –0.58, P < 0.001) as well as increased circulating C-reactive protein ( r = –0.57, P = 0.0002), IL-6 ( r = –0.40, P < 0.01), ADMA ( r = –0.37, P = 0.02), and ET-1 ( r = –0.44, P < 0.01). Finally, choroidal thinning was associated with renal histological inflammation and arterial stiffness. In a model of hypertension, choroidal thinning was seen only in the presence of renal injury. CONCLUSIONS. Chorioretinal thinning in CKD is associated with lower eGFR and greater proteinuria, but not BP. Larger studies, in more targeted groups of patients, are now needed to clarify whether these eye changes reflect the natural history of CKD. Similarly, the associations with arterial stiffness, inflammation, and endothelial dysfunction warrant further examination. TRIAL REGISTRATION. Registration number at www.clinicalTrials.gov: NCT02132741. SOURCE OF FUNDING. TR was supported by a bursary from the Erasmus Medical Centre, Rotterdam. JJMHvB was supported by a bursary from the Utrecht University. JRC is supported by a Rowling Scholarship. SB was supported by a Wellcome Trust funded clinical research fellowship from the Scottish Translational Medicine and Therapeutics Initiative, and by a Rowling Scholarship, at the time of this work. ND is supported by a British Heart Foundation Intermediate Clinical Research Fellowship (FS/13/30/29994).

1 January 2021 in Clinical Nutrition
Verified
Journal Article
Closed access
MMMorag Jane MacMaster
Morag Jane MacMaster
SDSpyridoula Damianopoulou
Spyridoula Damianopoulou
CTChristina Thomson
Christina Thomson
DTDinesh Talwar
Dinesh Talwar
FSFiona Stefanowicz
Fiona Stefanowicz
DGDaniel R. Gaya
Daniel R. Gaya

5 November 2022 in Nutrition in Clinical Practice
Verified
Journal Article
Closed access
MBMette M. Berger
Mette M. Berger
DTDinesh Talwar
Dinesh Talwar
ASAlan Shenkin
Alan Shenkin

Verified
Journal Article
Open access
PDF file
DMDonogh Maguire
Donogh Maguire
ONOgnian Neytchev
Ognian Neytchev
DTDinesh Talwar
Dinesh Talwar
DMDonald C McMillan
Donald C McMillan
PSPaul Shiels
Paul Shiels
Telomere biology, a key component of the hallmarks of ageing, offers insight into dysregulation of normative ageing processes that accompany age-related diseases such as cancer. Telomere homeostasis is tightly linked to cellular metabolism, and in particular with mitochondrial physiology, which is also diminished during cellular senescence and normative physiological ageing. Inherent in the biochemistry of these processes is the role of magnesium, one of the main cellular ions and an essential cofactor in all reactions that use ATP. Magnesium plays an important role in many of the processes involved in regulating telomere structure, integrity and function. This review explores the mechanisms that maintain telomere structure and function, their influence on circadian rhythms and their impact on health and age-related disease. The pervasive role of magnesium in telomere homeostasis is also highlighted.

9 December 2023 in Clinical Nutrition
Verified
Journal Article
Open access
MBMette M. Berger
Mette M. Berger
Karin AmreinKarin Amrein
Karin Amrein
RBRocco Barazzoni
Rocco Barazzoni
LBLaure Bindels
Laure Bindels
IBIrene Bretón-Lesmes
Irene Bretón-Lesmes
AZArthur R.H. van Zanten
Arthur R.H. van Zanten
The European Society for Clinical Nutrition and Metabolism published its first clinical guidelines for use of micronutrients (MNs) in 2022. A two-day web symposium was organized in November 2022 discussing how to apply the guidelines in clinical practice. The present paper reports the main findings of this symposium. Current evidence was discussed, the first day being devoted to clarifying the biology underlying the guidelines, especially regarding the definition of deficiency, the impact of inflammation, and the roles in antioxidant defences and immunity. The second day focused on clinical situations with high prevalence of MN depletion and deficiency. The importance of the determination of MN status in patients at risk and diagnosis of deficiencies is still insufficiently perceived, considering the essential role of MNs in immune and antioxidant defences. Epidemiological data show that deficiencies of several MNs (iron, iodine, vitamin D) are a global problem that affects human health and well-being including immune responses such as to vaccination. Clinical conditions frequently associated with MN deficiencies were discussed including cancer, obesity with impact of bariatric surgery, diseases of the gastrointestinal tract, critical illness, and aging. In all these conditions, MN deficiency is associated with worsening of outcomes. The recurrent problem of shortage of MN products, but also lack of individual MN-products is a worldwide problem. Despite important progress in epidemiology and clinical nutrition, numerous gaps in practice persist. MN depletion and deficiency are frequently insufficiently searched for in clinical conditions, leading to inadequate treatment. The symposium concluded that more research and continued education are required to improve patient outcome.

22 December 2010 in European Journal of Clinical Investigation
Verified
Journal Article
Closed access
PDF file
SBScott Blackwell
Scott Blackwell
DODenis St J. O’rEilly
Denis St J. O’rEilly
DRDavid Reid
David Reid
DTDinesh Talwar
Dinesh Talwar